Literature DB >> 12554887

Risk factors of readmission to hospital for a COPD exacerbation: a prospective study.

J Garcia-Aymerich1, E Farrero, M A Félez, J Izquierdo, R M Marrades, J M Antó.   

Abstract

BACKGROUND: Exacerbations of chronic obstructive pulmonary disease (COPD) are a leading cause of admission to hospital among men in many countries, although the factors causing exacerbations are largely unknown. The association between readmission for a COPD exacerbation and a wide range of modifiable potential risk factors, after adjusting for sociodemographic and clinical factors, has been assessed.
METHODS: Three hundred and forty patients with COPD recruited during an admission for an exacerbation in four tertiary hospitals in the Barcelona area of Spain were followed for a mean period of 1.1 years. Information on potential risk factors, including clinical and functional status, medical care and prescriptions, medication adherence, lifestyle, health status, and social support, was collected at the recruitment admission. A Cox's proportional hazards model was used to obtain independent relative risks of readmission for COPD.
RESULTS: During the follow up period 63% of patients were readmitted at least once, and 29% died. The final multivariate model showed the following risk (or protective) factors: > or =3 admissions for COPD in the year before recruitment (hazard ratio (HR)=1.66, 95% CI 1.16 to 2.39), forced expiratory volume in 1 second (FEV(1)) percentage predicted (0.97, 95% CI 0.96 to 0.99), oxygen tension (0.88, 95% CI 0.79 to 0.98), higher levels of usual physical activity (0.54, 95% CI 0.34 to 0.86), and taking anticholinergic drugs (1.81, 95% 1.11 to 2.94). Exposure to passive smoking was also related to an increased risk of readmission with COPD after adjustment for clinical factors (1.63, 95% CI 1.04 to 2.57) but did not remain in the final model.
CONCLUSIONS: This is the first study to show a strong association between usual physical activity and reduced risk of readmission to hospital with COPD, which is potentially relevant for rehabilitation and other therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12554887      PMCID: PMC1746561          DOI: 10.1136/thorax.58.2.100

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  31 in total

1.  Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease.

Authors:  I M Osman; D J Godden; J A Friend; J S Legge; J G Douglas
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

2.  Is pulmonary rehabilitation an effective treatment for chronic obstructive pulmonary disease? Yes.

Authors:  B R Celli
Journal:  Am J Respir Crit Care Med       Date:  1997-03       Impact factor: 21.405

3.  Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)

Authors:  A F Connors; N V Dawson; C Thomas; F E Harrell; N Desbiens; W J Fulkerson; P Kussin; P Bellamy; L Goldman; W A Knaus
Journal:  Am J Respir Crit Care Med       Date:  1996-10       Impact factor: 21.405

4.  Validation of the Minnesota Leisure Time Physical Activity Questionnaire in Spanish men. The MARATHOM Investigators.

Authors:  R Elosua; J Marrugat; L Molina; S Pons; E Pujol
Journal:  Am J Epidemiol       Date:  1994-06-15       Impact factor: 4.897

5.  Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study.

Authors:  H Cabello; A Torres; R Celis; M El-Ebiary; J Puig de la Bellacasa; A Xaubet; J González; C Agustí; N Soler
Journal:  Eur Respir J       Date:  1997-05       Impact factor: 16.671

6.  Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease.

Authors:  F Maltais; P LeBlanc; C Simard; J Jobin; C Bérubé; J Bruneau; L Carrier; R Belleau
Journal:  Am J Respir Crit Care Med       Date:  1996-08       Impact factor: 21.405

7.  Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81.

Authors:  N Pearce; J Grainger; M Atkinson; J Crane; C Burgess; C Culling; H Windom; R Beasley
Journal:  Thorax       Date:  1990-03       Impact factor: 9.139

8.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

Authors:  N R Anthonisen; J Manfreda; C P Warren; E S Hershfield; G K Harding; N A Nelson
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

9.  Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force.

Authors:  N M Siafakas; P Vermeire; N B Pride; P Paoletti; J Gibson; P Howard; J C Yernault; M Decramer; T Higenbottam; D S Postma
Journal:  Eur Respir J       Date:  1995-08       Impact factor: 16.671

10.  Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD.

Authors:  R E Wegner; R A Jörres; D K Kirsten; H Magnussen
Journal:  Eur Respir J       Date:  1994-04       Impact factor: 16.671

View more
  164 in total

1.  Physical activity patterns of patients with cardiopulmonary illnesses.

Authors:  Huong Q Nguyen; Bonnie G Steele; Cynthia M Dougherty; Robert L Burr
Journal:  Arch Phys Med Rehabil       Date:  2012-07-05       Impact factor: 3.966

Review 2.  COPD exacerbations. 4: Prevention.

Authors:  S Scott; P Walker; P M A Calverley
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

3.  Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study.

Authors:  J Garcia-Aymerich; P Lange; M Benet; P Schnohr; J M Antó
Journal:  Thorax       Date:  2006-05-31       Impact factor: 9.139

4.  Caring for the burden of COPD.

Authors:  P M A Calverley
Journal:  Thorax       Date:  2006-10       Impact factor: 9.139

Review 5.  Effect of treatments on the progression of COPD: report of a workshop held in Leuven, 11-12 March 2004.

Authors:  M Decramer; R Gosselink; P Bartsch; C-G Löfdahl; W Vincken; R Dekhuijzen; J Vestbo; R Pauwels; R Naeije; T Troosters
Journal:  Thorax       Date:  2005-04       Impact factor: 9.139

6.  Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease.

Authors:  Michael Spencer; Andrew H Briggs; Ronald F Grossman; Laureen Rance
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

7.  Effects of Integrated Case Payment on Medical Expenditure and Readmission of Inpatients with Chronic Obstructive Pulmonary Disease: A Nonrandomized, Comparative Study in Xi County, China.

Authors:  Meng Shi; Jing Wang; Liang Zhang; Yan Yan; Yu-Dong Miao; Xiang Zhang
Journal:  Curr Med Sci       Date:  2018-06-22

8.  The impact of SHS exposure on health status and exacerbations among patients with COPD.

Authors:  Mark D Eisner; Carlos Iribarren; Edward H Yelin; Stephen Sidney; Patricia P Katz; Gabriela Sanchez; Paul D Blanc
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-05-07

9.  Incidence and risk factors of exacerbations among COPD patients in primary health care: APMPOC study.

Authors:  Eulàlia Borrell; Mar Rodríguez; Pere Torán; Laura Muñoz; Guillem Pera; Núria Montellà; Mònica Monteagudo; Magalí Urrea; Yolanda Puigfel; Antonio Negrete; Xavier Mezquiriz; Cristina Domènech; Anna Lacasta; Ma Llum García; Sandra Maneus; Glòria Tintoré
Journal:  BMC Public Health       Date:  2009-01-09       Impact factor: 3.295

Review 10.  Strategies for improving outcomes of COPD exacerbations.

Authors:  Tom Wilkinson; J A Wedzicha
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.